News und Analysen
Puma Biotechnology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the H.C. Wainwright 22nd Annual Global Investment Conference
QIAGEN führt portablen Schnelltest ein, der mehr als 30 Proben pro Stunde auf das SARS-CoV-2-Antigen untersuchen kann
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute Pläne zur Einführung eines portablen Schnelltests bekannt gegeben, der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene
Navidea Biopharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 Antigen
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a rapid portable test that can detect SARS-CoV-2 antigens in people with active infections in less than 15 minutes
Positive Initial Data From a Phase 1 Trial With Transgene’s Oncolytic Virus TG6002
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces first positive data from the Phase
Charles River Laboratories to Present at September Investor Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:
-
Wells Fargo 2020 Healthcare
Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that results from the Phase 3 IMPALA study were published online in NEJM. The manuscript, titled “Inhaled Molgramostim
Biopharma Leaders Unite to Stand with Science
The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX), GlaxoSmithKline plc (LSE/NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), known as MSD outside the United States
Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...
Canopy Growth (WKN: A140QA) goes online: Mit dem neuen Online-Store ShopCanopy versucht das Unternehmen aus Smith Falls, Kanada, seine E-Commerce-Aktivitäten zu intensivieren.
Doch bei einem
THERANEXUS : DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS
Lyon, September 7, 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction
CO.DON AG: Behandlung von Patienten in der Schweiz begonnen
Berlin / Teltow / Leipzig, 07. September 2020 – Das INSELSPITAL Bern, Universitätsspital der Universität Bern hat als erste Schweizer Klinik mit der Behandlung von Patienten mit dem 100 %
CO.DON AG: Treatment of patients starts in Switzerland
Berlin / Teltow / Leipzig, 07 September 2020 – The INSELSPITAL in Bern, Bern’s university hospital, has become the first Swiss clinic to start treating patients with the 100% autologous
Relay & Fio Corp. prüfen Marktentwicklung und COVID-19-Anwendungen für Fionet
- Regierung, Medien und Ärzte stimmen sich über die Notwendigkeit von routinemäßigen, kontrollierten Tests an Flughäfen, Arbeitsplätzen, zu Hause und an anderen dezentralen Orten
Relay & Fio Corp. Address Market Development and Fionet COVID-19 Applications
- Government, Media, and Doctors Are Aligning on Need for Routine, Controlled Testing at Airports, Workplaces, Homes, and Other Decentralized Locations
- Health Canada
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today
NANOBIOTIX Announces Half-year Financial Statements as at June 30, 2020
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN: FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer
Acadia Healthcare to Participate in Baird 2020 Global Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Baird 2020 Global Healthcare Conference, which is being held as a virtual event on September
MEDICREA Reports First Half 2020 Results
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences:
-
Steve Pacelli, Executive Vice President
PerkinElmer to Present at BofA Global Healthcare Conference 2020
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Global Healthcare Conference 2020 on
Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo
Illumina arbeitet mit 54gene bei der Schaffung einer Genomik-Einrichtung von Weltklasse in Nigeria zusammen
Illumina, Inc. (NASDAQ: ILMN) gab heute eine Zusammenarbeit mit 54gene bekannt, einem Unternehmen der Gesundheitstechnologie, dessen Aufgabe es ist, die Fähigkeiten der Präzisionsmedizin in Afrika
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on September 2, 2020 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
Premier Inc. to Present at Upcoming Investor Conferences
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at two upcoming investor conferences:
-
Baird